SMARCA4 and neoplasm: Thus, SMARCD3 may not have a robust impact on early tumor initiation, although its restricted ductal expression in the normal mouse pancreas (as opposed to the ubiquitous expression of SMARCA4) suggests a potential role in ductal fate (Supplementary Fig. 5e).